Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon.

@article{Veldt2006LongtermCO,
  title={Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon.},
  author={Bart J. Veldt and Bettina E Hansen and Kenji Ikeda and E. R. Verhey and Hiroshi Tiberu Suzuki and Solko W. Schalm},
  journal={Scandinavian journal of gastroenterology},
  year={2006},
  volume={41 9},
  pages={1087-94}
}
OBJECTIVE Patients with chronic hepatitis C who do not respond to interferon can be treated with glycyrrhizin to reduce disease activity. The objective of this study was to evaluate the effect of glycyrrhizin on the incidence of hepatocellular carcinoma (HCC) during long-term follow-up after non-response to interferon. MATERIAL AND METHODS We analyzed individual patient data of all consecutive patients treated with interferon in 12 major Japanese hospitals between 1990 and 1995 who showed no… CONTINUE READING